These molecular changes align with the maladaptive cardiac remodeling observed in advanced AS and position SGLT2 not only as a metabolic transporter but also as a central node linking inflammation, fibrosis, and energetic dysfunction in the diseased myocardium [98]. Here, SLC5A2 is linked to aortic valve stenosis.